A Bright Opportunity for Growth

The time to integrate innovative and unprecedented solution for dry eyes is here.

Dry eye disease (DED) is one of the most common eye conditions, reportedly affecting about 49 million Americans of which only half are diagnosed. Other reports suggest that the actual number of people suffering from DED symptoms is much higher, up to 130 million American adults. Therefore, it is not surprising that 45% existing ophthalmology and optometry patients suffer from DED. Yet treatments have remained widely unsatisfactory, until now.

In this eBook, we will discuss the magnitude of dry eye disease, the advantages OptiLight offers to patients suffering from DED, and the exciting opportunity it presents to elevate your practice.